HEMACHAP-REVIEW-RODAKS-6th-ed. Flashcards
- What procedure is NOT employed to validate a new assay?
a. Comparison of assay results to a
reference method
b. Test for assay precision
c. Test for assay linearity
d. Moving average algorithm
d. Moving average algorithm
- You validate a new assay using linear regression to compare assay calibrator results with the distributor’s published cali- brator results. The slope is 0.99 and
the y intercept is 110%. What type of error is present?
a. No error
b. Random error
c. Constant systematic error
d. Proportional systematic error
c. Constant systematic error
- Which is a statistical test that compares means?
a. Bland-Altman
b. Student t-test
c. ANOVA
d. Pearson
b. Student t-test
- The acceptable hemoglobin control value range is 13 6 0.4 g/dL. The control is assayed five times and produces the
following five results: 12.0 g/dL 12.3 g/dL 12.0 g/dL 12.2 g/dL 12.1 g/dL These results are:
a. Accurate but not precise
b. Precise but not accurate
c. Both accurate and precise
d. Neither accurate nor precise
b. Precise but not accurate
- A WBC count control has a mean value of
6000/mL and an SD of 300/mL. What is the 95.5% confidence interval?
a. 3000 to 9000/mL
b. 5400 to 6600/mL
c. 5500 to 6500/mL
d. 5700 to 6300/mL
b. 5400 to 6600/mL
- The ability of an assay to distinguish the targeted analyte from interfering substances within the specimen matrix is called:
a. Analytical specificity
b. Analytical sensitivity
c. Clinical specificity
d. Clinical sensitivity
a. Analytical specificity
- A laboratory scientist measures prothrombin time for plasma aliquots from 15 healthy men and 15 healthy women. She computes the mean and 95.5% confidence interval and notes that they duplicate the manufacturer’s statistics within 5%. This procedure is known as:
a. Setting the RI
b. Confirming linearity
c. Determining the therapeutic range
d. Establishing the RI by transference
d. Establishing the RI by transference
- You perform a clinical efficacy test and get the following results:
What is the number of false-negative results?
a. 45
b. 40
c. 10
d. 5
d. 5
- The laboratory purchases reagents from a manufacturer and develops an assay using a protocol published in a vol- ume of the Methods in Molecular Biology series. How would the FDA classify this assay?
a. Cleared
b. Research use only
c. Analyte-specific reagent
d. Laboratory-developed test
d. Laboratory-developed test
- What agency provides external quality
assurance (proficiency) surveys and laboratory accreditation?
a. Clinical Laboratory Improvement Advisory Committee (CLIAC)
b. Centers for Medicare and Medicaid
Services (CMS)
c. College of American Pathologists (CAP)
d. The Joint Commission
c. College of American Pathologists (CAP)
- You purchase a preserved whole blood
specimen from a distributor who provides the mean values for several com- plete blood count analytes. What is this specimen called?
a. Normal specimen
b. Calibrator
c. Control
d. Blank
c. Control
2.The glycocalyx is composed of membrane:
a. Phospholipids and cholesterol
b. Glycoproteins and glycolipids
c. Transmembrane and cytoskeletal proteins
d. Rough and smooth endoplasmic reticulum
b. Glycoproteins and glycolipids
- What agency provides continuing medical laboratory education?
a. Clinical Laboratory Improvement
Advisory Committee (CLIAC)
b. American Society for Clinical
Laboratory Science (ASCLS)
c. Centers for Medicare and Medicaid
Services (CMS)
d. College of American Pathologists (CAP)
b. American Society for Clinical
Laboratory Science (ASCLS)
- Regular review of blood specimen collection quality is an example of:
a. Postanalytical quality assurance
b. Preanalytical quality assurance
c. Analytical quality control
d. External quality assurance
b. Preanalytical quality assurance
- Review of laboratory report integrity is an example of:
a. Postanalytical quality assurance
b. Preanalytical quality assurance
c. Analytical quality control
d. External quality assurance
a. Postanalytical quality assurance
- When performing a receiver operating curve analysis, what parameter assesses the overall efficacy of an assay?
a. Area under the curve
b. Performance limit (threshold)
c. Positive predictive value
d. Negative predictive value
a. Area under the curve
- You require your laboratory staff to annually perform manual lupus anticoagulant profiles on a set
of plasmas with known values. This exercise is known as:
a. Assay validation
b. Proficiency testing
c. External quality assessment
d. Pre-pre analytical variable assay
b. Proficiency testing
- The organelle involved in packaging and
trafficking of cellular products is the:
a. Nucleus
b. Golgi apparatus
c. Mitochondria
d. Rough endoplasmic reticulum
b. Golgi apparatus
- The “control center” of the cell is the:
a. Nucleus
b. Cytoplasm
c. Membrane
d. Microtubular system
a. Nucleus
- The nucleus is composed largely of:
a. RNA
b. DNA
c. Ribosomes
d. Glycoproteins
b. DNA
- The site of protein synthesis is the:
a. Nucleus
b. Mitochondria
c. Ribosomes
d. Golgi apparatus
c. Ribosomes
- The shape of a cell is maintained by which of the following?
a. Microtubules
b. Spindle fibers
c. Ribosomes
d. Centrioles
a. Microtubules
- Functions of the cell membrane include all of the following except:
a. Regulation of molecules entering or
leaving the cell
b. Receptor recognition of extracellular
signals
c. Maintenance of electrochemical
gradients
d. Lipid production and oxidation
d. Lipid production and oxidation
- The energy source for cells is the:
a. Golgi apparatus
b. Endoplasmic reticulum
c. Nucleolus
d. Mitochondrion
d. Mitochondrion